🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, dose escalation and expansion study to evaluate the ...
Status
Recruiting
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2021-03-24
Trial ID
NCT04665206
Treatments Being Tested
This is an open-label, single-arm, multicenter, exploratory Phase II study ...
Status
Terminated
Location
Research Site
Start Date
2022-01-19
Trial ID
NCT05215951
Treatments Being Tested
This study aimed to evaluate the anticancer activity of capmatinib in combi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2021-09-22
Trial ID
NCT04816214
Treatments Being Tested
Global, Phase 3, randomized, multicenter, open-label study evaluating the e...
Status
Recruiting
Location
St. Jude Medical Center
Start Date
2025-12-17
Trial ID
NCT07185997
Treatments Being Tested
The purpose of this study is to confirm the tolerability of recommended Pha...
Status
Active Not Recruiting
Location
USC Norris Comprehensive Cancer Center
Start Date
2019-09-04
Trial ID
NCT04077463
Treatments Being Tested
The objective of this Phase II, open-label, multicenter, non-randomised con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-01-01
Trial ID
NCT06692491
Treatments Being Tested
This trial is testing two novel combinations (temozolomide plus osimertinib...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-10-29
Trial ID
NCT04541407
Treatments Being Tested
The objective of our study is to assess the risk of immune-related adverse ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07-01
Trial ID
NCT04115410
Treatments Being Tested
IFCT-2202 ROSIE study aims to incorporate a broad-panel centralized NGS tes...
Status
Recruiting
Location
Angers - CHU
Start Date
2024-01-22
Trial ID
NCT06053099
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935